Advertisement
High doses of omega-3 fatty acids may protect against further damage in myocardial infarction patients

ACC: High-Dose Omega-3 Protects Heart Following MI

0
Survivors who took large, daily dose of prescription-only capsules showed less decline in heart function
Patients with atrial fibrillation who take digoxin may face a nearly 30 percent greater risk of death than patients not taking the drug

ACC: Mortality Risk Up With Digoxin Use in A-Fib

0
May face a nearly 30 percent greater risk of death than patients not taking the drug
Statin drugs may significantly increase a person's risk of developing type 2 diabetes

Statins Tied to Decreased Insulin Sensitivity, Secretion

0
Large Finnish study found a nearly 50 percent increase in DM for people taking statins
A mobile phone application has been released to identify current drug shortages

FDA Launches First App to Identify Drug Shortages

0
App IDs shortages, resolved shortages, product discontinuation; can be used to report shortages
An experimental Ebola vaccine may have prevented the disease in a doctor who was at high risk of infection

Post-Occupational Exposure Ebola Vaccination Shows Promise

0
High-risk situation led doctor to get immunization; no serious illness developed
For patients with atrial fibrillation receiving anticoagulant treatment

Anemia Linked to Adverse Outcomes in Atrial Fibrillation

0
Increased risk of thromboembolic events, bleeding complications, mortality during anticoagulant tx
Most primary care physicians are aware of state prescription drug monitoring programs

Many PCPs Not Using Rx Drug Monitoring Programs Routinely

0
Barriers to use include time-consuming nature of information retrieval; lack of intuitive format for data
U.S. Food and Drug Administration approval of Opdivo (nivolumab) has been expanded to include advanced non-small-cell lung cancer

FDA: Opdivo Approval Expanded to Include Lung Cancer

0
FDA approves drug for NSCLC patients who have been treated with platinum-based chemotherapy
Adults with eczema have a major health burden with significantly increased health care utilization and costs

Major Health, Cost Burden for U.S. Patients With Eczema

0
U.S. adults with eczema spent over $29 billion in out-of-pocket health costs in 2012
Resistance to commonly used antimicrobials is increasing in Salmonella and Campylobacter

Resistance to Common Antimicrobials Increasing

0
Salmonella, Campylobacter show significant resistance in humans and animals